DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Diéras V, Miles D, Verma S, Pegram M, Welslau M, Baselga J. et al.
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): A descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.
Lancet Oncol 2017;
18: 732-42
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.